Overview
Medtronic's Neuromodulation division is a global leader in deep brain stimulation (DBS), spinal cord stimulation, and targeted drug delivery for conditions including Parkinson's disease, essential tremor, chronic pain, and epilepsy. Their Percept PC DBS system with BrainSense technology enables real-time neural sensing during therapy delivery.
More in Neuromodulation
Latest industry news
Closed-Loop BCIs Charted as Next Frontier for Depression, Anxiety, and PTSD Treatment
2026-07-21 · Research
Instruments of Self-Knowledge: How Cognitive Assessment Tech Is Making the Invisible Mind Measurable
2026-07-21 · Industry
Top 10 Technologies Turning Self-Awareness Into Something You Can Actually See
2026-07-21 · Industry
China Clears Brain-Computer Interfaces for Commercial Use, Prompting Calls for Global Regulatory Alignment
2026-07-20 · Policy
Company details
Category
⚡ Neuromodulation
Location
Dublin, Ireland
Funding
NYSE: MDT
Listed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →